Future research directions include developing more targeted and efficient nanoparticle delivery systems for PGC-1, further verifying therapeutic efficacy for metastatic bladder cancer, and exploring combinations with other treatments such as chemotherapy, immunotherapy, or radiotherapy for enhanced therapeutic outcomes
Lipid nanoparticle-mediated codelivery of Cas9 mRNA and single-guide RNA achieves liver-specific in vivo genome editing of Angptl3
Insulin Resistance and Prediabetes
How PlexusDx Supports a More Personalized Approach PlexusDx uses only licensed 503A compounding pharmacies, ensuring every formulation meets state board standards, USP sterility requirements, and FDA compliance
doi: 10.1016/j.coesh.2024.100568 84 Rezende-TeixeiraP.DusiR
Your dose schedule is individualized based on your starting weight, metabolic health, and tolerance